It gives us immense pleasure to invite you all to the “International Congress on Frontiers in Urologic Oncology and Uropathology” - an international conference that will take place in the temple city of Bhubaneswar, Odisha, India, from 10th to 12th January, 2025, jointly organized by the Genitourinary Pathology Society, Kalinga Institute of Medical sciences, International Association for Integrated Oncology, All India Institute of Medical Sciences- Bhubaneswar, Odisha Society of Oncology, Urological Society of India – Uro-oncology Division and Medical Education Unit with the mission to foster a global community of urologic researchers and professionals, providing a platform for intellectual growth, and creating opportunities for networking and collaboration.
Indeed, this would be the first such event that will bring together world-renowned Oncologists, pathologists, and urologists, who work in the field of genitourinary oncology onto to a common platform. The academic event will be beneficial for the budding as well as practicing pathologists, urologists, and oncologists. It will also provide opportunity to physicians for meeting and networking with the stalwarts in the field of urologic oncology.
The topics covered over the three days are designed to cater to the needs of all those who are interested in urologic pathology, urology, and urologic oncology. A panel of fifteen international faculties who are the experts in their fields will grace the event which makes it a coveted one to learn about the entire realm of urologic pathology and oncology. In addition, there will be presentation and quiz for the budding physicians (trainees in pathology, urology, and oncology) which make it a much sought after event.
15th September 2024
31st October 2024
01st November 2024
01st November 2024
AIIMS Bhubaneswar
Nadiad
USC Keck School of Medicine
UT Southwestern University
Applications of Digital and Computational Pathology and Artificial Intelligence in Genitourinary Pathology Diagnostics – Dr. Mahul Amin
Multiparametric MRI in Prostate Cancer Diagnosis and Management: Role of Pathologist – Dr. Cristina Magi-Galluzzi (9:15 AM-10:00 AM, 45 minutes)
Contemporary Update on Prostate Cancer Grading – Dr. Ming Zhou (10:00 AM-10:45 AM, 45 Minutes)
Divergent Differentiations and Variant Histologies of Bladder Cancer – Dr. Gladell Paner (11:00 AM – 11:45 AM, 45 Minutes)
How New Developments Impact Diagnosis in Existing Renal Neoplasms – Dr. Sean Williamson (11:45 AM – 12:30 PM, 45 minutes )
Germ Cell Tumors of the Testis: Diagnoses that You Do Not Want to Miss – Dr. Andres Acosta (1:30 PM- 2:15 pm, 45 Minutes)
Penile Cancer: A pathologist’s perspective for current trends in diagnosis, staging, and treatment – Dr. Jasreman Dhillon (2:15 PM- 3:00 PM, 45 Minutes)
Case-based discussions (15 Minutes + 5 Minutes for Q&A):
Communicating Pathology Results for Personalized Medicine: How Are the Surgical Members of the Society of Urologic Oncology Using Pathology Reports to Guide the Treatment of Prostate Cancer Patients? - Dr. Murali Varma (8:30 AM- 9:15 AM, 45 Minutes)
Large Gland Lesions of the Prostate: Current Concepts, Controversies, and Future directions – Dr. Rajal Shah (9:15 AM- 10:00 AM, 45 minutes)
Pathologic sub-staging of bladder cancer – updates, controversies, and guidelines – Dr. Ankur Sangoi (10:00 AM- 10:45 AM, 45 minutes)
Pink Cell Tumors of the Kidney: Making Sense – Dr. Rohit Mehra (11:00 AM-11:45 AM, 45 minutes)
Best practice recommendation for immunohistochemical markers in renal cell tumors – Dr. Mahmut Akgul (11:45 AM- 12:30 PM, 45 minutes)
Quiz- Dr Akhil Kapoor (1.30 PM to 1.35 PM, 5 minutes)
Non-muscle invasive bladder cancer: Management principles and recent advances - Dr. Ravimohan (1.35 PM to 1.50 PM, 15 minutes)
Debate: Bladder Preservation Strategies in Bladder Cancer - Combined modality treatment is preferred over Radical cystectomy in locally advanced bladder cancer -1.50 PM to 2.10 PM, 20 minutes
Dr. Manas Pradhan : 8 minutes
Dr Indraneel (Radiation oncologist) : 8 minutes
Expert comment : Dr. Surendra N. Senapati
4. Panel discussion : 2.10 PM - 2.45 PM, 35 minutes
Neoadjuvant and adjuvant strategies in bladder cancer.
Moderator : Dr. Vineet Talwar
Metastatic Urothelial Carcinoma: New Horizons with emphasis on Antibody Drug Conjugates: Keynote speech: Dr. Ajjai Alva (2.45 PM - 3.15 PM, 30 minutes)
Clinical management of subtype histologies of bladder cancer (15 min): 3.15 PM - 3.30 PM Dr Anita Ramesh
Renal cell carcinoma: (1 hour 45 minutes)
Quiz : Dr. Srigopal Mohanty (3.45 PM - 3.50 PM, 5 minutes)
Small renal masses: approach and Current guidelines: Dr. Ravindra Sabnis – (3.50 PM - 4.05 PM, 15 minutes)
Debate RCC: Adjuvant immunotherapy is the current standard of care in newly diagnosed RCC – (4.05 PM - 4.25 PM, 20 minutes)
For : Dr. Atul Batra
Against : Dr. Amol Akhade
Expert comments : Dr. Dipti R. Samanta
Combining systemic therapy with local therapy (SBRT) in MRCC - Dr Srinivas Chilikuri (4.25 PM - 4.40 PM, 15 minutes)
Panel discussion : Metastatic clear cell carcinoma: Case based discussion – (4.40 PM - 5.15 PM, 35 minutes)
Moderator : Dr. Atul Sharma
Sarcomatoid Kidney : important diagnostic and therapeutic considerations –Keynote: Dr. Philippe Speiss (5.15 PM - 5.45 PM, 30 minutes)
Prostate Cancer Screening: Controversies and Consensus - The latest guidelines and evidence. Dr. Chirag Desai (9:00 AM – 9:15 AM, 15 minutes)
3. Debate: Use of next generation imaging is preferred over conventional imaging in management of advanced prostate cancer: 9:15 AM – 9:35 AM, 20 minutes
For: Dr. Kanhaiya Agarwal
Against: Dr. Manas Kar
Expert comment: Dr. Chirag Desai
4. Oligometastatic prostate cancer: Current understanding and consensus on multi-modality management-Dr. Sandy Srinivas (9:35 AM – 10:05 AM, 30 minutes) (Keynote address)
5. Panel discussion: Locally advanced prostate cancer 9:50 AM - 10:20 AM, 30 minutes
Moderator: Dr. Vedang Murthy
Metastatic hormone sensitive prostate cancer the right sequence-Dr Amit Joshi (10:20 AM-10:40 AM, 20 minutes)
Panel discussion: Castrate resistant prostate cancer (10.40AM- 11.10 AM, 30 minutes)
Moderator: Dr. T. Raja
Miscellaneous: (2 hours)
1. Role of HPV in the management of penile cancer: Where do we stand? Dr. Philippe Speiss- (11.25 AM to 11.55 AM, 30 minutes)
2. Genitourinary malignancies: Making sense of Indian data with emphasis on conducting collaborative research- Dr. Atul Batra (11.55 AM to 12.10 PM, 15 minutes)
3. Neuroendocrine carcinoma in urogenital tract: Multimodality management in case-based discussions-12.10 PM to 12.40 PM, 30 minutes
Moderator: Dr. Senthil Rajappa
Note : International Congress on Uro Oncology & Pathology proceedings series will be submitted to the Web of Science Book Citation Index (BkCI) and to SCOPUS for evaluation and indexing.
BHUBANESWAR, INDIA
gupsindiaconclave@iaoncology.org
+91-8925642775
+12027548501 (USA, Canada and Others)
International Congress on Uro Oncology & Pathology an international conference that will take place in the temple city of Bhubaneswar, Odisha, India, from 10th to 12th January, 2025.
gupsindiaconclave@iaoncology.org
Copyright © 2024. All Rights Reserved
